Royal Bank Of Canada Talis Biomedical Corp Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.44 - $0.54 $11 - $14	27 Added 21.95%	150 $0
Q4 2022 Feb 14, 2023	SELL	$0.45 - $11.67 $88 - $2,298	-197 Reduced 61.56%	123 $0
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.44 $678 - $1,206	-838 Reduced 72.37%	320 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $2,314 - $7,458	-1,780 Reduced 60.59%	1,158 $1,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $4,004 - $6,484	1,051 Added 55.7%	2,938 $11,000
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $4,310 - $8,921	716 Added 61.14%	1,887 $12,000
Q2 2021 Aug 16, 2021	BUY	$9.62 - $14.56 $11,265 - $17,049	1,171 New	1,171 $13,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.